Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland (Q51590425)
Jump to navigation
Jump to search
scientific article published on 16 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland |
scientific article published on 16 January 2010 |
Statements
Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland (English)
1 reference
Norman Putzki
1 reference
Ozgür Yaldizli
1 reference
Robert Bühler
1 reference
Guido Schwegler
1 reference
Daniela Curtius
1 reference
Barbara Tettenborn
1 reference
16 January 2010
1 reference
63
1 reference
2
1 reference
101-106
1 reference